Cure SMA | Home

We can see a future without SMA.

SMA is the number one genetic cause of death for infants. But together, we're making real progress toward a treatment and cure.

We will be hosting more than 50 events—including walk-n-rolls, marathons, galas, golf tournaments, and bowl-a-thons—from Vermont to California

Every year, Cure SMA sponsors a conference to bring together the leading SMA researchers, clinicians, and families living with SMA.

We now have 17 active drug programs in the pipeline, including six in clinical trials.

Sign up for the latest SMA information

Let us help you connect to the resources you need

January 21, 2015

Matthew A. Halanski, a Cure SMA-funded researcher from University of Wisconsin – Madison, was the lead author on, "Assessing the Needs of the SMA...

Matthew A. Halanski, a Cure SMA-funded researcher from University of Wisconsin – Madison, was the lead author on, "Assessing the Needs of the SMA...

January 19, 2015

January 20 is a day dedicated to the social acceptance of disability and to honor the late...

January 20 is a day dedicated to the social acceptance of disability and to honor the late...

January 17, 2015

Swiss drugmaker Roche has agreed to buy privately-held Trophos. Roche, the third largest pharmaceutical company in the world,...

Swiss drugmaker Roche has agreed to buy privately-held Trophos. Roche, the third largest pharmaceutical company in the world,...